Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-07-02-Speech-2-230"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-07-02"^^xsd:date2
dcterms:Is Part Of	lp_eu:Question Time (Commission)2
dcterms:Language	"es"^^xsd:language2
lpv:document identification number	"en.20020702.10.2-230"2
lpv:hasSubsequent	lp_eu:2002-07-02-Speech-2-2312
lpv:speaker	lp:Alonso José Puerta2
lpv:spokenAs	unknown; Izquierda Unida (1999-07-20--2004-07-19)3 substitute; AFCO (2002-01-17--2004-07-19)3 member; Delegation for relations with the countries of Central America and Mexico (2002-02-07--2004-07-19)3 vice-president; Parliament's Bureau (2002-01-15--2004-07-19)3 member_of_the_bureau; EUL/NGL (1999-10-13--2004-07-19)3 member; Committee on Regional Policy, Transport and Tourism (2002-01-17--2004-07-19)3 vice-president; European Parliament (2002-01-15--2004-07-19)3
lpv:translated text	"Question No 59 by Margrietus J. van den Berg (): Would the Commission outline the progress which has been made at the WTO towards meeting the Doha commitment to ensure that the TRIPS agreement does not obstruct affordable access to medicines in countries with little or no domestic manufacturing capacity in the pharmaceutical industry? Would the Commission confirm that the EU will press for a solution which ensures access to medicines for WTO member countries on terms equivalent to those set out in the Doha Declaration on TRIPS and medicines? Does the Commission accept that an agreement to allow production for export under Article 30 of TRIPS most clearly meets the spirit of the Doha Agreement, by locating any decision on compulsory licensing only in the country of consumption?"@en1
lpv:unclassifiedMetadata	"President."1 "Subject: The TRIPS Agreement and access to medicines"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph